Abstract
A new hypoxic cell radiosensitizer, Ro 03-8799, has been administered i.v. to 2 normal and 6 patient volunteers. Generally in non-necrotic tumours the concentrations obtained were 3 times greater than in plasma sampled at the same time. These observations added to the reports concerning toxicology in monkeys and rats and radiosensitizing efficiency in the laboratory, suggest that Ro 03-8799 may prove to be much more effective sensitizer than misonidazole in man.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dische S., Saunders M. I., Riley P. J., Hauck J., Bennett M. H., Stratford M. R., Minchinton A. I. The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid. Br J Cancer. 1981 Mar;43(3):344–349. doi: 10.1038/bjc.1981.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dische S., Saunders M. I., Stratford M. R. Neurotoxicity with desmethylmisonidazole. Br J Radiol. 1981 Feb;54(638):156–157. doi: 10.1259/0007-1285-54-638-156. [DOI] [PubMed] [Google Scholar]
- Rich T. A., Dische S., Saunders M. I., Stratford M. R., Minchinton A. A serial study of the concentration of misonidazole in human tumors correlated with histologic structure. Int J Radiat Oncol Biol Phys. 1981 Feb;7(2):197–203. doi: 10.1016/0360-3016(81)90437-5. [DOI] [PubMed] [Google Scholar]
- Williams M. V., Denekamp J., Minchinton A. I., Stratford M. R. In vivo assessment of basic 2-nitroimidazole radiosensitizers. Br J Cancer. 1982 Jul;46(1):127–137. doi: 10.1038/bjc.1982.174. [DOI] [PMC free article] [PubMed] [Google Scholar]